Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Felice Leonardi"'
Autor:
Brett Hauber, Peita Graham-Clarke, Marco Boeri, Russel Burge, Sandra Florez, Antje Tockhorn-Heidenreich, Maria Fernandez, Felice Leonardi
Publikováno v:
Patient Preference and Adherence. 14:1049-1064
Purpose Teriparatide is used to treat patients with established osteoporosis but is often reserved for patients who have inadequate response to antiresorptive therapy. Biosimilar teriparatide, which is believed to have efficacy and safety similar to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5450245c8c108cd427d404c897ac427
https://doi.org/10.2147/ppa.s250745
https://doi.org/10.2147/ppa.s250745
Autor:
Emmanuel Papadimitropoulos, Alan Brnabic, Ellen Vorstenbosch, Felice Leonardi, Sebastian Moyano, Diana Gomez
Publikováno v:
International journal of rheumatic diseasesREFERENCES. 25(4)
Rheumatoid arthritis (RA) is a chronic autoimmune disease which, when left untreated, may result in the destruction of multiple joints and damage a wide variety of body systems, including the skin, eyes, lungs, heart, and blood vessels. The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a20c5faab18338d951b2111a4af310e
https://pubmed.ncbi.nlm.nih.gov/35102697
https://pubmed.ncbi.nlm.nih.gov/35102697
Autor:
Peita L, Graham-Clarke, Brett, Hauber, Marco, Boeri, Felice, Leonardi, Russel T, Burge, Maria, Fernandez, Antje, Tockhorn-Heidenreich, Sandra, Florez
Publikováno v:
Patient preference and adherence
Purpose Teriparatide is used to treat patients with established osteoporosis but is often reserved for patients who have inadequate response to antiresorptive therapy. Biosimilar teriparatide, which is believed to have efficacy and safety similar to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d4b322812df9816b5c13ed16e068d939
https://pubmed.ncbi.nlm.nih.gov/32612354
https://pubmed.ncbi.nlm.nih.gov/32612354
Autor:
Josep Maria Haro, Sara Siddi, Diego Novick, Felice Leonardi, Daniel Lee Kay Pen, Juan Carlos Velasquez, Maria Victoria Moneta, Cristina Avendaño, M E Montoya-Restrepo
Publikováno v:
Journal of medical economics. 22(9)
Aims: To assess patient and disease characteristics, treatment patterns, and associated costs in patients with advanced or metastatic gastric cancer (A/MGC) in Colombia, in both the public ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f6c97a179425075567f100f756792a
https://pubmed.ncbi.nlm.nih.gov/31066594
https://pubmed.ncbi.nlm.nih.gov/31066594
Autor:
Felice Leonardi, Alexander Rodríguez, Alejandra Hernández, Oscar F. Sánchez, Carlos J. Alméciga-Díaz, Lina Maria Lizaraso, Alejandra Coronado, Carlos Soto, Roció Sierra, Jorge Bohorquez, Olga Velasquez, Luis A. Barrera, Angela Espejo, Angela Mosquera
Publikováno v:
Journal of Microbiology and Biotechnology. 23:689-698
The production and characterization of an active recombinant N-acetylgalactosamine-6-sulfate sulfatase (GALNS) in Escherichia coli BL21(DE3) has been previously reported. In this study, the effect of the signal peptide (SP), inducer concentration, pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d609c98b2ecd5ec0b55f5a792d0391e
https://doi.org/10.4014/jmb.1211.11044
https://doi.org/10.4014/jmb.1211.11044
Autor:
Angela Mosquera, Carlos Soto, Carlos J. Alméciga-Díaz, Felice Leonardi, Oscar F. Sánchez, Luis A. Barrera, Alexander Rodríguez, Angela Espejo
Publikováno v:
Process Biochemistry. 47:2097-2102
Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) enzyme. Currently, specific therapies are not available for MPS IVA patients. In this study, a biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a46ce9f5020f20a7af79f766018fc36f
https://doi.org/10.1016/j.procbio.2012.07.028
https://doi.org/10.1016/j.procbio.2012.07.028
Autor:
Diego Rosselli, María Camila Plata, Laura Baquero, Juan Diego Aristizabal-Mayor, Camilo Castañeda-Cardona, Ana María Leguizamón, JJ Triana, Felice Leonardi, Sebastián Gil-Tamayo, Mauricio Medina
Publikováno v:
Revista Colombiana de Gastroenterología. 32:326
Objetivo: El cáncer gástrico es la segunda causa de muerte por cáncer y la quinta neoplasia más frecuente en el mundo. En Colombia, es la primera causa de mortalidad por cáncer. La incidencia y mortalidad anuales son 16,3 y 14,2/100.000 habitant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e6fcc7098fdb81fb7c63a6916e6f72f
https://doi.org/10.22516/25007440.175
https://doi.org/10.22516/25007440.175